7 May 2021 Pilot of new health technology evaluation process for antimicrobials SMC announce pilot of new health technology evaluation process for antimicrobials.
12 April 2021 April 2021 decisions news release Advice on four new medicines published Advice on four new medicines for use in conditions including multiple myeloma and severe migraine has today (Monday 12 April) been published by the Scottish Medicines Consortium. A new medicine for Duchenne Muscular Dystrophy has now also been included in the ultra-orphan pathway.
31 March 2021 Two more COVID-19 treatments available through UK-wide initiative involving SMC Two more medicines can now be used to treat COVID-19, thanks to a UK-wide multi-agency initiative involving the Scottish Medicines Consortium (SMC).
8 March 2021 March 2021 decisions news release SMC accepts medicines for rare genetic disease in children and cancer tumours with genetic abnormality. Medicines which can be used to treat a rare genetic disease in children and some cancer tumours with a genetic abnormality have today (Monday 8 March) been accepted by the Scottish Medicines Consortium (SMC) for use by NHSScotland.
8 February 2021 February 2021 decisions news release SMC accepts four new medicines for use by NHSScotland The Scottish Medicines Consortium (SMC), which advises on newly licensed medicines for use by NHSScotland, has today (Monday 8 February) published advice on four new medicines.
18 January 2021 January 2021 decisions news release SMC accepts five new medicines for use by NHSScotland The Scottish Medicines Consortium (SMC), which advises on newly licensed medicines for use by NHSScotland, has today (Monday 18 January) published advice accepting five new medicines.
29 December 2020 SMC to support innovative new medicines pathway SMC, NICE and MHRA to work on new Innovative Licensing and Access Pathway Experts from the Scottish Medicines Consortium (SMC) are to support a new licensing and access pathway which aims to reduce the time to market for innovative new medicines, allowing patients benefit from them more quickly.
7 December 2020 December 2020 decisions news release Medicines for blood cancer and rare muscle disorder accepted for use by NHSScotland Medicines which can be used to treat a form of blood cancer and a rare muscle disorder have today (Monday 7 December) been accepted by the Scottish Medicines Consortium (SMC) for use by NHSScotland.
10 November 2020 Patient access schemes (PAS) – process revision From November 2020 our process has changed to align the arrangements for Patient Access Schemes (PAS) across all submissions.
